Treatment of diabetes
CA 2334116 A1 · Owner: Efendic, Suad · Inventors: Apelqvist, Theresa; Efendic, Suad
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Use of a liver-selective glucocorticoid antagonist preferably the compound , having formula (I) in the preparation of a pharmaceutical composition for the treatment of diabetes. A composition for the treatment of diabetes containing such a glucocorticoid antagonist, and a method of treating diabetes using the composition.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 7, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 7, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 7, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.